Publications of Johannes Ruhnau

Ruhnau, J., Grote, V., Juárez-Osorio, M., Bruder, D., Mahour, R., Rapp, E., Rexer, T., & Reichl, U. (2021)Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike GlycoproteinFrontiers in Bioengineering and Biotechnology, 9, 699026doi: 10.3389/fbioe.2021.699025.

Wenzel, L., Ruhnau, J., Rexer, T., & Reichl, U.Chemoenzymatic glycosylation of polypeptides using eukaryotic oligosaccharyltransferase and synthetic lipid-linked glycansPresented at: Glyco26Taipei (Taiwan), August 27, 2023.

Ruhnau, J.Cell-free Glycoengineering of the recombinant SARS-CoV-2 spike glycoproteinPresented at: 15th Bratislava Symposium on Saccharides (15BSS) Smolenice (Slovakia), June 20, 2022.

Wenzel, L., Ruhnau, J., Hoffmann, M., Rexer, T., & Reichl, U.Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme CascadePresented at: GlycoBioTec 2023Berlin, Germany, January 14, 2023.

Wenzel, L., Ruhnau, J., Rexer, T., & Reichl, U.Synthesis of synthetic lipid-linked oligosaccharides for the in-vitro glycoengineering of peptidesPresented at: 15th Bratislava Symposium on Saccharides (15BSS)Smolenice (Slovakia), June 20, 2022.

Ruhnau, J., Grote, V., Juárez-Osorio, M., Bruder, D., Mahour, R., Rapp, E., Rexer, T., & Reichl, U.Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike GlycoproteinPresented at: glycoNET2021virtually, September 22, 2021.